[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0301883D0 - New use II - Google Patents

New use II

Info

Publication number
SE0301883D0
SE0301883D0 SE0301883A SE0301883A SE0301883D0 SE 0301883 D0 SE0301883 D0 SE 0301883D0 SE 0301883 A SE0301883 A SE 0301883A SE 0301883 A SE0301883 A SE 0301883A SE 0301883 D0 SE0301883 D0 SE 0301883D0
Authority
SE
Sweden
Prior art keywords
inhibitor
new use
hsd1
mammal
promotion
Prior art date
Application number
SE0301883A
Other languages
English (en)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301883A priority Critical patent/SE0301883D0/sv
Publication of SE0301883D0 publication Critical patent/SE0301883D0/sv
Priority to PCT/SE2004/000956 priority patent/WO2004112781A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0301883A 2003-06-25 2003-06-25 New use II SE0301883D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301883A SE0301883D0 (sv) 2003-06-25 2003-06-25 New use II
PCT/SE2004/000956 WO2004112781A1 (en) 2003-06-25 2004-06-16 New use ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301883A SE0301883D0 (sv) 2003-06-25 2003-06-25 New use II

Publications (1)

Publication Number Publication Date
SE0301883D0 true SE0301883D0 (sv) 2003-06-25

Family

ID=27656618

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301883A SE0301883D0 (sv) 2003-06-25 2003-06-25 New use II

Country Status (2)

Country Link
SE (1) SE0301883D0 (sv)
WO (1) WO2004112781A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005247929B2 (en) 2004-05-24 2010-03-11 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
EP1866298A2 (en) 2005-03-31 2007-12-19 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
BRPI0610459A2 (pt) 2005-04-05 2010-06-22 Hoffmann La Roche composto, processo para a sua preparação, composições farmacêuticas que o compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de deidrogenase de hidroxiesteróides-11b e utilização do composto
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
EP1951696A2 (en) 2005-11-22 2008-08-06 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BRPI0710479A2 (pt) 2006-01-18 2012-08-14 Hoffmann La Roche composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100359397B1 (ko) * 1995-04-04 2002-11-01 텍사스 바이오테크놀로지 코포레이션 엔도텔린의 활성을 조절하는 비페닐설폰아미드 및 이의 유도체
DE69718038D1 (de) * 1996-10-16 2003-01-30 American Cyanamid Co Herstellung und verwendung von ortho-sulfonamido-heteroarylhydroxamsäuren als matrix-metalloproteinase und tace inhibitoren
SE0001899D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
WO2004112781A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
SE0301882D0 (sv) New use I
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
BR9916785A (pt) Tratamento de asma com inibidores mek
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
DE602006010442D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
ATE484508T1 (de) Furylverbindungen
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
SE0301883D0 (sv) New use II
SE0201940D0 (sv) New combination II
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
ATE443044T1 (de) Tace inhibitoren
SE0004101D0 (sv) New use
SE0301885D0 (sv) New use IV
SE0301884D0 (sv) New use III
SE0002739D0 (sv) New use
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung